Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 4
2005 2
2007 2
2008 2
2009 4
2010 3
2012 3
2013 3
2014 3
2015 8
2016 5
2017 4
2018 2
2019 10
2020 17
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

70 results
Results by year
Filters applied: . Clear all
Page 1
Drug repositioning: a brief overview.
Jourdan JP, Bureau R, Rochais C, Dallemagne P. Jourdan JP, et al. Among authors: dallemagne p. J Pharm Pharmacol. 2020 Sep;72(9):1145-1151. doi: 10.1111/jphp.13273. Epub 2020 Apr 17. J Pharm Pharmacol. 2020. PMID: 32301512 Free PMC article. Review.
Facing the complexity of Alzheimer's disease.
Dallemagne P, Rochais C. Dallemagne P, et al. Future Med Chem. 2020 Feb;12(3):175-177. doi: 10.4155/fmc-2019-0310. Epub 2019 Nov 21. Future Med Chem. 2020. PMID: 31747794 Free article. No abstract available.
hERG toxicity assessment: Useful guidelines for drug design.
Garrido A, Lepailleur A, Mignani SM, Dallemagne P, Rochais C. Garrido A, et al. Among authors: dallemagne p. Eur J Med Chem. 2020 Jun 1;195:112290. doi: 10.1016/j.ejmech.2020.112290. Epub 2020 Apr 3. Eur J Med Chem. 2020. PMID: 32283295 Review.
Therapeutic Potential of 5-HT6 Receptor Agonists.
Karila D, Freret T, Bouet V, Boulouard M, Dallemagne P, Rochais C. Karila D, et al. Among authors: dallemagne p. J Med Chem. 2015 Oct 22;58(20):7901-12. doi: 10.1021/acs.jmedchem.5b00179. Epub 2015 Jul 2. J Med Chem. 2015. PMID: 26099069 Review.
5-HT4R modulators: a patent landscape.
Dallemagne P, Rochais C. Dallemagne P, et al. Pharm Pat Anal. 2021 Jul;10(4):179-181. doi: 10.4155/ppa-2021-0017. Epub 2021 Aug 9. Pharm Pat Anal. 2021. PMID: 34365797 No abstract available.
70 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page